Asymptomatic neurocognitive impairment in people with HIV does predict later neurocognitive symptoms
Rilpivirine + darunavir HIV maintenance regimen matches standard three-drug antiretroviral therapy
Your next steps booklet highly commended in the British Medical Association awards
US PrEP care cascade analysis suggests that major, structural barriers need to be addressed for PrEP to have an impact
Medicines Patent Pool looks at hepatitis C
Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs
